Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance. This is page number 12.
Order by Relevance | Date
Total 1783 results found since Jan 2013.
Healing of Severe Herpes Zoster Ophthalmicus Within a Few Days: An Autobiographical Case Report
Cureus. 2021 Dec 9;13(12):e20303. doi: 10.7759/cureus.20303. eCollection 2021 Dec.ABSTRACTHerpes zoster (shingles) is caused by the herpes zoster virus and is characterized by pain and unilateral vesicular rash that typically affects one dermatome. Symptoms tend to resolve over 10-15 days. This case report describes the 75-year-old author's herpes zoster ophthalmicus (HZO) accompanied by severe orbital edema. The upper eyelid and the proximal nasal area were also affected. The author felt an intermittent throbbing pain in more than three dermatomes including the frontal, orbital, temporal, and occipital/nuchal areas. Since...
Source: Herpes - January 13, 2022 Category: Infectious Diseases Authors: Tibor Bakacs Source Type: research
Herpes Zoster (HZ) dermatitis in a COVID-19 vaccinated healthy male after one dose of varicella vaccine
JAAD Case Rep. 2022 Jan 21. doi: 10.1016/j.jdcr.2021.12.043. Online ahead of print.NO ABSTRACTPMID:35079617 | PMC:PMC8776645 | DOI:10.1016/j.jdcr.2021.12.043
Source: Herpes - January 26, 2022 Category: Infectious Diseases Authors: Farshid Etaee Tarek Naguib Steven Daveluy Source Type: research
Vaccination in rheumatic disease patients: results of a pilot quality improvement program
CONCLUSIONS: The implementation of a pilot vaccination QI program led by rheumatology fellows-in-training showed promising preliminary benefits in the vaccination uptake among RD patients and helps to evaluate the barriers to surpass.PMID:35079179 | PMC:PMC8768043 | DOI:10.5114/reum.2021.112349
Source: Herpes - January 26, 2022 Category: Infectious Diseases Authors: Gabriel Figueroa-Parra Andrea Moreno-Salinas Leticia Santoyo-Fexas Carmen Magdalena Gamboa-Alonso Juan Pablo Carrizales-Luna Ivan de Jesus Hernandez-Galarza Dionicio Angel Galarza-Delgado Jorge Antonio Esquivel-Valerio Source Type: research
Covid-19 vaccination and possible link to Herpes zoster
CONCLUSIONS: Herpes zoster may be a side effect of m RNA vaccination against the Sars-CoV2 vaccine and requires further investigation.PMID:35097240 | PMC:PMC8789478 | DOI:10.1016/j.ajoc.2022.101359
Source: Herpes - January 31, 2022 Category: Infectious Diseases Authors: D R Lazzaro R Ramachandran E Cohen S L Galetta Source Type: research
Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study
This study aimed to evaluate the effect of inactivated virus (CoronaVac, Sinovac) and mRNA (BNT162b2, BioNTech/Fosun Pharma) COVID-19 vaccine on the risk of herpes zoster related hospitalization.METHODS: Self-controlled case series (SCCS) analysis was conducted using the data from the electronic health records in Hospital Authority and COVID-19 vaccination records in the Department of Health in Hong Kong. We conducted the SCCS analysis including patients with a first primary diagnosis of herpes zoster in the hospital inpatient setting between February 23 and July 31, 2021. A confirmatory analysis by nested case-control met...
Source: Herpes - February 7, 2022 Category: Infectious Diseases Authors: Eric Yuk Fai Wan Celine Sze Ling Chui Yuan Wang Vanessa Wai Sei Ng Vincent Ka Chun Yan Francisco Tsz Tsun Lai Xue Li Carlos King Ho Wong Esther Wai Yin Chan Christina Sze Man Wong Kathy Sze Man Leung Michael Yuxuan Ni Sophie Alessandra Valkenburg Joseph S Source Type: research
Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
CONCLUSIONS: HZ risk was not significantly different between RZV recipients with and without concomitant vaccination, supporting recommendations allowing for concomitant administration of RZV with other vaccines.PMID:35146050 | PMC:PMC8825562 | DOI:10.1093/ofid/ofac011
Source: Herpes - February 11, 2022 Category: Infectious Diseases Authors: Katia J Bruxvoort Lei Qian Jun Wu Ana Florea Bradley Ackerson Lina S Sy Leticia Vega Daily Harpreet Takhar Hung Fu Tseng Source Type: research
Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: A two-vaccine related event?
Metabol Open. 2022 Mar;13:100171. doi: 10.1016/j.metop.2022.100171. Epub 2022 Feb 10.ABSTRACTReactivation of varicella-zoster virus (VZV) has been reported after the administration of different vaccine platforms against SARS-CoV-2, also among individuals without known immunosuppressive states. Herein, we describe for the first time a case of herpes zoster after mRNA vaccination against SARS-CoV-2 in a 53-year-old immunocompetent adult without any known comorbidities, who was previously vaccinated with a live attenuated zoster vaccine. The fact that the patient had no history of varicella and had been tested seronegative fo...
Source: Herpes - February 16, 2022 Category: Infectious Diseases Authors: Natalia G Vallianou Dimitrios Tsilingiris Irene Karampela Junli Liu Maria Dalamaga Source Type: research
Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report
We describe the case of VZV meningitis post BNT162b2 mRNA vaccination in a young immunocompetent patient. A 39-year-old patient with no medical history presented with a vesicular rash, headache, nausea and fever, days after receiving BNT162b2 mRNA vaccination. CSF analysis revealed a pleocytosis, and VZV DNA was confirmed by PCR testing. The patient received intravenous aciclovir with resolution of symptoms within 48 h. He was discharged after 14 days of treatment. Case reports of herpes zoster reactivation post vaccination and details of subsequent successful vaccination course completion have allowed us to recommend the ...
Source: Herpes - February 21, 2022 Category: Infectious Diseases Authors: Colm Kerr Susan O'Neill Anna Szucs Oliver Darmody Claire Williamson Ciaran Bannan Concepta Merry Source Type: research
Herpes Zoster Ophthalmicus: A Devastating Disease Coming Back with Vengeance or Finding Its Nemesis?
J Ophthalmic Vis Res. 2022 Jan 21;17(1):123-129. doi: 10.18502/jovr.v17i1.10177. eCollection 2022 Jan-Mar.ABSTRACTHerpes zoster ophthalmicus is a frequent, painful, and debilitating condition caused by the reactivation of the varicella-zoster virus alongside the ophthalmic branch of the trigeminal nerve. Twenty-five percent of adults will develop the disease during their lifetime with the risk increasing to one in two over the age of 50. Herpes zoster ophthalmicus presents with a plethora of ocular manifestations ranging from the characteristic rash in the distribution of the ophthalmic branch of the fifth cranial nerve to...
Source: Herpes - February 23, 2022 Category: Infectious Diseases Authors: Michael Tsatsos Ioannis Athanasiadis Athina Myrou George M Saleh Nikolaos Ziakas Source Type: research
Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report
We describe the case of VZV meningitis post BNT162b2 mRNA vaccination in a young immunocompetent patient. A 39-year-old patient with no medical history presented with a vesicular rash, headache, nausea and fever, days after receiving BNT162b2 mRNA vaccination. CSF analysis revealed a pleocytosis, and VZV DNA was confirmed by PCR testing. The patient received intravenous aciclovir with resolution of symptoms within 48 h. He was discharged after 14 days of treatment. Case reports of herpes zoster reactivation post vaccination and details of subsequent successful vaccination course completion have allowed us to recommend the ...
Source: Herpes - February 21, 2022 Category: Infectious Diseases Authors: Colm Kerr Susan O'Neill Anna Szucs Oliver Darmody Claire Williamson Ciaran Bannan Concepta Merry Source Type: research
Herpes Zoster Ophthalmicus: A Devastating Disease Coming Back with Vengeance or Finding Its Nemesis?
J Ophthalmic Vis Res. 2022 Jan 21;17(1):123-129. doi: 10.18502/jovr.v17i1.10177. eCollection 2022 Jan-Mar.ABSTRACTHerpes zoster ophthalmicus is a frequent, painful, and debilitating condition caused by the reactivation of the varicella-zoster virus alongside the ophthalmic branch of the trigeminal nerve. Twenty-five percent of adults will develop the disease during their lifetime with the risk increasing to one in two over the age of 50. Herpes zoster ophthalmicus presents with a plethora of ocular manifestations ranging from the characteristic rash in the distribution of the ophthalmic branch of the fifth cranial nerve to...
Source: Herpes - February 23, 2022 Category: Infectious Diseases Authors: Michael Tsatsos Ioannis Athanasiadis Athina Myrou George M Saleh Nikolaos Ziakas Source Type: research
